Literature DB >> 17276053

TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins.

Florence Armstrong1, Laurence Lamant, Corinne Hieblot, Georges Delsol, Christian Touriol.   

Abstract

Translocations of the anaplastic lymphoma kinase (ALK) gene result in the production of a number of oncogenic ALK fusion proteins implicated in tumour development. We have previously shown that X-ALK fusion proteins have differential effects on the proliferation, transformation, and invasion properties of NIH3T3 cells in vitro. In the present study, we have investigated the metastatic potential of various X-ALK expressing cell lines using an experimental lung metastasis assay. We have shown that TPM3-ALK expression bestows higher metastatic capacities than other X-ALK fusion proteins and in addition, that TPM3-ALK fusion protein expression specifically induces changes in cell morphology and cytoskeleton organisation. Co-immunoprecipitation studies demonstrate a specific interaction between TPM3-ALK and endogenous tropomyosin. Together the specific actions of TPM3-ALK on the cytoskeleton organisation offer an interesting hypothesis with respect to the higher cell motility and metastatic potential of this fusion protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276053     DOI: 10.1016/j.ejca.2006.12.005

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  16 in total

1.  Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls.

Authors:  Yuzhuo Wang; Olga Y Gorlova; Ivan P Gorlov; Meng Zhu; Juncheng Dai; Demetrius Albanes; Stephen Lam; Adonina Tardon; Chu Chen; Gary E Goodman; Stig E Bojesen; Maria Teresa Landi; Mattias Johansson; Angela Risch; Heunz-Erich Wichmann; Heike Bickeboller; David C Christiani; Gad Rennert; Susanne M Arnold; Paul Brennan; John K Field; Sanjay Shete; Loïc Le Marchand; Olle Melander; Hans Brunnstrom; Geoffrey Liu; Rayjean J Hung; Angeline S Andrew; Lambertus A Kiemeney; Shanbeh Zienolddiny; Kjell Grankvist; Mikael Johansson; Neil E Caporaso; Penella J Woll; Philip Lazarus; Matthew B Schabath; Melinda C Aldrich; Victoria L Stevens; Hongxia Ma; Guangfu Jin; Zhibin Hu; Christopher I Amos; Hongbing Shen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-10       Impact factor: 4.254

2.  An inflammatory myofibroblastic tumour of the breast with ALK overexpression.

Authors:  Yan Zhou; Jiang Zhu; Yi Zhang; Jun Jiang; Ming Jia
Journal:  BMJ Case Rep       Date:  2013-02-04

3.  Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.

Authors:  Xuchao Zhang; Shirley Zhang; Xuening Yang; Jinji Yang; Qing Zhou; Lucy Yin; Shejuan An; Jiaying Lin; Shiliang Chen; Zhi Xie; Mike Zhu; Xiaolin Zhang; Yi-long Wu
Journal:  Mol Cancer       Date:  2010-07-13       Impact factor: 27.401

4.  Detecting the exposure to Cd and PCBs by means of a non-invasive transcriptomic approach in laboratory and wild contaminated European eels (Anguilla anguilla).

Authors:  Lucie Baillon; Fabien Pierron; Jennifer Oses; Pauline Pannetier; Eric Normandeau; Patrice Couture; Pierre Labadie; Hélène Budzinski; Patrick Lambert; Louis Bernatchez; Magalie Baudrimont
Journal:  Environ Sci Pollut Res Int       Date:  2015-11-14       Impact factor: 4.223

5.  Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma.

Authors:  Hye-Sun Choi; Seon-Hee Yim; Hai-Dong Xu; Seung-Hyun Jung; Seung-Hun Shin; Hae-Jin Hu; Chan-Kwon Jung; Jong Young Choi; Yeun-Jun Chung
Journal:  BMC Cancer       Date:  2010-04-01       Impact factor: 4.430

6.  Label-free quantitative mass spectrometry reveals a panel of differentially expressed proteins in colorectal cancer.

Authors:  Nai-Jun Fan; Jiang-Ling Gao; Yan Liu; Wei Song; Zhan-Yang Zhang; Chun-Fang Gao
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

7.  ALK gene amplification is associated with poor prognosis in colorectal carcinoma.

Authors:  P Bavi; Z Jehan; R Bu; S Prabhakaran; N Al-Sanea; F Al-Dayel; M Al-Assiri; T Al-Halouly; R Sairafi; S Uddin; K S Al-Kuraya
Journal:  Br J Cancer       Date:  2013-10-15       Impact factor: 7.640

Review 8.  Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies.

Authors:  Sandrine Medves; Jean-Baptiste Demoulin
Journal:  J Cell Mol Med       Date:  2012-02       Impact factor: 5.310

9.  An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform.

Authors:  Amandine Bastide; Zeineb Karaa; Stéphanie Bornes; Corinne Hieblot; Eric Lacazette; Hervé Prats; Christian Touriol
Journal:  Nucleic Acids Res       Date:  2008-02-26       Impact factor: 16.971

10.  Key contribution of eIF4H-mediated translational control in tumor promotion.

Authors:  Charlotte Vaysse; Céline Philippe; Yvan Martineau; Cathy Quelen; Corinne Hieblot; Claire Renaud; Yvan Nicaise; Aurore Desquesnes; Maria Pannese; Thomas Filleron; Ghislaine Escourrou; Malcolm Lawson; Robert C Rintoul; Marie Bernadette Delisle; Stéphane Pyronnet; Pierre Brousset; Hervé Prats; Christian Touriol
Journal:  Oncotarget       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.